(Treffer aus pharmind, Nr. 09, Seite 1270 (2016))
Francas D | Müßig R | Gmür A
Supply Chain Management / Part 2: Creating value with regional logistics hubs
Part 1 see Pharm Ind. 2015;77(10):1452–1457. · Francas D, Müßig R, Gmür A · 1
Camelot Management Consultants AG, Mannheim und 2
Camelot Management Consultants AG, Basel, Switzerland
The world pharmaceutical market was worth an estimated 865 billion U.S. dollars at ex-factory prices in 2014, whereas the North American market (USA and Canada) remained the world’s largest market with a 44.5 % share, followed by Europe (25.3 % share) and Japan (8.9 % share). However, the growth rates in emerging economies such as Brazil, China and India far exceed the rates in mature markets [ 1 , 2 ]. The predominant distribution model for pharma companies is to rely on dispersed—and mostly historically grown—distribution networks with one or several local distribution centers (DCs) in each market. For instance, rather than using ...